DIRECTED RETROVIRAL INFECTION OF NKG2D⁺ MURINE NATURAL KILLER CELLS BY DISPLAYING THE NKG2D LIGAND RAE-1y ON THE VIRUS SURFACE

dc.contributor.authorSanford, Michael Edwin
dc.contributor.departmentHood College Biology
dc.contributor.programBiomedical and Environmental Science
dc.date.accessioned2024-03-18T18:57:13Z
dc.date.available2024-03-18T18:57:13Z
dc.date.issued2008-12
dc.description.abstractNatural Killer (NK) cells are unique in having the ability to lyse both virally infected cells and tumor cells unrestricted by the major histocompatibility complex (MHC). Given their promise as a therapeutic tool, studying their biology through expressing or repressing genes, would greatly enhance our understanding of these cells and how to use them for clinical purposes. As NK cells are extremely difficult to genetically engineer, the goal of this research project was to create targeted retroviral particles that were capable of increasing transduction of NKG2D⁺ NK cells over nontargeted retroviral particles. To achieve this goal, we generated retroviral particles containing RAE-1y, a ligand for the NK cell receptor NKG213. Using this method, we were able to test the hypothesis that expressing an NK. receptor ligand on retroviral particles would increase the infection efficiency of NKG2D⁺ NK cells. Our results demonstrated that expressing the RAE-1y ligand in the cells producing retroviral particles did not increase the efficiency of NK cell retroviral infection.
dc.format.extent110 pages
dc.genreThesis (M.S.)
dc.identifierdoi:10.13016/m2qf5p-sado
dc.identifier.urihttp://hdl.handle.net/11603/32061
dc.language.isoen_US
dc.titleDIRECTED RETROVIRAL INFECTION OF NKG2D⁺ MURINE NATURAL KILLER CELLS BY DISPLAYING THE NKG2D LIGAND RAE-1y ON THE VIRUS SURFACE
dc.typeText

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sanford, Michael.pdf
Size:
3.34 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.65 KB
Format:
Item-specific license agreed upon to submission
Description: